[ad_1]
Lung cancer is one of the most common cancers in the world.1 The results are among the poorest of all tumor types, with a five-year survival of 10 to 20%.2 Survival is strongly influenced by stage at diagnosis, with five-year survival ranging from 92% to 0% for the earliest and most recent stages, respectively.3 In this update, we discuss contemporary therapeutic options and approaches to increase symptom awareness and early diagnosis. Low dose CT screening is beyond the scope of this badysis.
Sources and selection criteria
In addition to researching Clinical Evidence and the Cochrane Collaboration, we have based this article on reference databases. We also reviewed the quotation lists of the included articles.
Who gets it?
Worldwide, about three-quarters of lung cancers are attributable to smoking; others are caused by occupational exposure in the workplace, exposure to radon and air pollution.4 It is more common in men and its incidence increases with age (Figure 1). Recent…
Source link
